Clinical features of CIDP with LM1-associated antibodies

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 5, 2013, Pages 573-575

  Kuwahara, Motoi ^a   Suzuki, Hidekazu ^a   Samukawa, Makoto ^a   Hamada, Yukihiro ^a   Takada, Kazuo ^a   Kusunoki, Susumu ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GM2; GANGLIOSIDE GQ 1B; GANGLIOSIDE GQ 1B ANTIBODY; GANGLIOSIDE GT 1B; GLYCOLIPID; GLYCOLIPID LM1; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LM1 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ARTICLE; ATAXIA; CEREBELLAR ATAXIA; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; COMPLEX FORMATION; CONTROLLED STUDY; CRANIAL NERVE INJURY; DISEASE ASSOCIATION; DORSAL ROOT; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENSORY ATAXIA; SEX DIFFERENCE;

EID: 84876138746     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303440     Document Type: Article

References (16)

1. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. J Periph Nerv Sys 2005;10:220-28.
2. Yan WX, Archelos JJ, Hartung HP, et al. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:286-92. (Pubitemid 32848730)
3. Allen D, Giannopoulos K, Gray I, et al. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2005;10:174-80. (Pubitemid 40984891)
4. Sanvito L, Makowska A, Mahdi-Rogers M, et al. Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 2009;80:333-38.
5. Hughes RA, Allen D, Makowska A, et al. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2006;11:30-46. (Pubitemid 43344973)
6. Ilyas AA, Mithen FA, Dalakas MC, et al. Antibodies to acidic glycolipids in Guillain-Barré syndrome and cronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1992;107:111-21.
7. Meléndez-Vásquez C, Redford J, Choudhary PP, et al. Immunological investigation of chronic inflammatory demyelinationg polyradiculoneuropathy. J Neuroimmunol 1997;73:124-34. (Pubitemid 27105278)
8. Kuwabara S, Ogawara K, Misawa S, et al. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002;72:37-42. (Pubitemid 34073093)
9. Kaida K, Morita D, Kanzaki M, et al. Ganglioside complexes: as new target antigens in Guillain-Barré syndrome. Ann Neurol 2004;56:567-71. (Pubitemid 39319349)
10. Ogawa-Goto K, Funamoto N, Ohta Y, et al. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from Cauda equine. J Neurochem 1992;59:1844-49.
11. Kuwahara M, Suzuki S, Takada K, et al. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 2011;239:87-90.
12. Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201. (Pubitemid 32738144)
13. Yako K, Kusunoki S, Kanazawa I. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome. J Neurol Sci 1999;168:85-89. (Pubitemid 29467424)
14. Susuki K, Yuki N, Hirata K, et al. Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome. J Neurol Sci 2002;195:145-48. (Pubitemid 34202291)
15. Kusunoki S, Chiba A, Tai T, et al. Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve 1993;16:752-56. (Pubitemid 23176092)
16. Chiba A, Kusunoki S, Obata H, et al. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 1997;745:32-6. (Pubitemid 27055743)